Aderbasib (intraperitoneal injection; 50 mg/kg; 5 days per week beginning four weeks; 2 weeks) blocks glioma growth of SU-pcGBM2 NSG mice xenografts[1].INCB7839 can be formulated in 2% DMSO, 2% Tween 80, 48% PEG300, 48% water as a injection solution. This is for literature reference only[1].
| Animal Model: | NSG mice[1] |
| Dosage: | 50 mg/kg |
| Administration: | Intraperitoneal injection; 50 mg/kg; 5 days per week beginning four weeks; 2 weeks |
| Result: | Robustly inhibited growth of pediatric glioblastoma orthotopic xenografts. |
